banner
p38-MAPK inhibitor VX-702, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ884

p38-MAPK inhibitor VX-702, Purity ≥98%

Synonym: VX-702; 745833-23-2; 479543-46-9; VX 702; VX702; 2-(2,4-Difluorophenyl)-6-(1-(2,6-difluorophenyl)ureido)nicotinamide; 1-(5-Carbamoyl-6-(2,4-difluorophenyl)pyridin-2-yl)-1-(2,6-difluorophenyl)urea; p38-MAPK inhibitor

  • MDL: MFCD11616590
  • CAS Number: 479543-46-9, 745833-23-2
  • Compound CID: 10341154
img
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
VX-702, soluble in DMSO and insoluble in ethanol and water, targets the ATP-binding site of the kinase, thereby preventing phosphorylation of downstream substrates. It targets p38 activation.
Molecular Weight
404.3
Molecular Formula
C19H12F4N4O2
Targets
p38 activation: 4-20 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 77 mg/mL (190.45 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
VX-702 can be used to study the effects of p38 MAP kinase inhibition in inflammatory and autoimmune diseases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0